Your browser is no longer supported. Please, upgrade your browser.
ACCD [NASD]
Accolade, Inc.
Index- P/E- EPS (ttm)-2.31 Insider Own1.00% Shs Outstand64.40M Perf Week3.59%
Market Cap2.62B Forward P/E- EPS next Y-2.03 Insider Trans0.00% Shs Float64.22M Perf Month-10.43%
Income-132.40M PEG- EPS next Q-0.74 Inst Own70.00% Short Float5.87% Perf Quarter-18.77%
Sales230.50M P/S11.39 EPS this Y-57.80% Inst Trans0.53% Short Ratio7.54 Perf Half Y-13.24%
Book/sh11.39 P/B3.49 EPS next Y32.80% ROA-17.10% Target Price56.36 Perf Year1.71%
Cash/sh- P/C- EPS next 5Y-0.90% ROE-27.20% 52W Range32.87 - 65.25 Perf YTD-8.57%
Dividend- P/FCF- EPS past 5Y- ROI-12.00% 52W High-38.72% Beta-
Dividend %- Quick Ratio1.70 Sales past 5Y- Gross Margin43.30% 52W Low21.64% ATR1.82
Employees2300 Current Ratio1.70 Sales Q/Q99.20% Oper. Margin-62.40% RSI (14)45.12 Volatility4.05% 4.29%
OptionableYes Debt/Eq0.38 EPS Q/Q-108.10% Profit Margin-57.40% Rel Volume0.16 Prev Close39.77
ShortableYes LT Debt/Eq0.38 EarningsOct 07 AMC Payout- Avg Volume499.54K Price39.98
Recom1.40 SMA20-1.23% SMA50-8.01% SMA200-15.59% Volume7,031 Change0.53%
Sep-30-21Initiated Berenberg Buy $61
Sep-17-21Upgrade Robert W. Baird Neutral → Outperform $58 → $54
May-28-21Initiated Robert W. Baird Neutral $54
May-06-21Upgrade SVB Leerink Mkt Perform → Outperform
Apr-15-21Initiated Needham Buy $59
Mar-11-21Resumed Goldman Buy $59
Jan-15-21Upgrade Credit Suisse Neutral → Outperform $45 → $60
Jan-07-21Initiated BTIG Research Buy $55
Dec-08-20Initiated Canaccord Genuity Buy $59
Sep-22-20Initiated DA Davidson Buy $45
Jul-27-20Initiated SVB Leerink Outperform $34
Jul-27-20Initiated Robert W. Baird Outperform $40
Jul-27-20Initiated Piper Sandler Overweight $45
Jul-27-20Initiated Morgan Stanley Overweight $37
Jul-27-20Initiated Goldman Buy $39
Jul-27-20Initiated Credit Suisse Neutral $38
Jul-27-20Initiated BofA Securities Buy $37
Oct-19-21 10:02AM  
Oct-14-21 09:01AM  
Oct-12-21 09:01AM  
Oct-11-21 08:38AM  
Oct-08-21 01:38PM  
05:30AM  
Oct-07-21 05:25PM  
04:05PM  
Oct-04-21 08:30AM  
Sep-30-21 03:00PM  
Sep-21-21 12:01PM  
Sep-20-21 09:14AM  
Sep-16-21 08:00AM  
Sep-09-21 06:07AM  
Sep-07-21 04:15PM  
Aug-17-21 09:05AM  
Aug-10-21 08:00AM  
Jul-21-21 11:52AM  
Jul-12-21 08:20AM  
Jul-11-21 03:17AM  
Jul-09-21 03:04AM  
Jul-08-21 09:30PM  
04:05PM  
Jul-07-21 09:08AM  
Jul-01-21 03:00PM  
Jun-24-21 02:15PM  
Jun-22-21 10:11AM  
Jun-17-21 08:00AM  
Jun-10-21 08:11AM  
Jun-09-21 04:15PM  
Jun-07-21 07:07AM  
Jun-03-21 05:00PM  
Jun-02-21 09:12AM  
Jun-01-21 06:00AM  
May-17-21 09:17AM  
May-10-21 11:00AM  
May-06-21 01:31AM  
May-05-21 07:03PM  
04:04PM  
Apr-23-21 07:00AM  
Apr-19-21 08:00AM  
Mar-25-21 04:29AM  
Mar-23-21 04:03PM  
04:02PM  
Mar-04-21 08:00AM  
Feb-16-21 08:00AM  
Feb-04-21 09:00AM  
Jan-31-21 11:18PM  
Jan-27-21 09:00AM  
Jan-14-21 06:00PM  
05:23PM  
04:50PM  
Jan-11-21 08:00AM  
Jan-07-21 10:31PM  
04:05PM  
02:30PM  
Dec-23-20 08:00AM  
Dec-17-20 05:00AM  
Dec-12-20 10:42AM  
Nov-20-20 08:00AM  
Oct-28-20 08:30AM  
Oct-26-20 04:05PM  
Oct-21-20 11:57PM  
Oct-19-20 04:28PM  
Oct-14-20 04:03PM  
03:00PM  
Oct-06-20 07:00AM  
Oct-02-20 06:58AM  
Oct-01-20 09:00AM  
Sep-24-20 06:00AM  
Sep-17-20 09:00AM  
Sep-01-20 08:30AM  
Aug-13-20 04:03PM  
Jul-27-20 09:00AM  
Jul-17-20 09:04PM  
Jul-07-20 02:11PM  
Jul-01-20 11:03PM  
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NEFF THOMAS JDirectorOct 07Option Exercise6.791,0967,44226,358Oct 12 10:47 AM
NEFF THOMAS JDirectorAug 27Option Exercise6.181,5129,34824,801Aug 31 09:01 AM
NEFF THOMAS JDirectorJul 22Option Exercise17.501793,13223,289Jul 23 12:41 PM
NEFF THOMAS JDirectorJul 21Option Exercise11.583,98346,14023,110Jul 23 12:41 PM
Frist William H.DirectorJun 16Option Exercise4.659164,255302,895Jun 21 10:38 AM
Frist William H.DirectorMay 12Option Exercise4.709174,310301,979May 13 09:51 PM
NEFF THOMAS JDirectorMay 07Option Exercise4.651,8348,52018,666May 10 03:46 PM
Frist William H.DirectorApr 27Option Exercise4.651,8338,515301,062Apr 28 02:53 PM
NEFF THOMAS JDirectorMar 16Option Exercise4.652,75012,77516,832Mar 18 11:37 AM
Frist William H.DirectorFeb 26Option Exercise4.634,58421,245299,229Mar 02 11:31 AM
NEFF THOMAS JDirectorJan 20Sale55.67161,5228,991,93014,082Jan 22 05:15 PM
NEFF THOMAS JDirectorDec 10Option Exercise4.654,83322,465175,604Dec 14 05:17 PM